CRP and cancer: It has been recently suggested that systemic inflammation-based scores such as GPS (including albumin and CRP values), NLR, and PLR might be significant predictors of OS and PFS of cancer patients (de Vivar Chevez et al. 2014; Feng et al. 2014; Raungkaewmanee et al. 2012; Hu et al. 2015; Song et al. 2016; Nakano et al. 2014; Templeton et al. 2014a, b; Keskin et al. 2014).